
The demand of safe sweeteners devoid of unwanted effects is based on the problems generated by the natural (i.e. Agave or Stevia) or artificial (acesulfame-K, aspartame, neotame, saccharin, and sucralose) products. The lack of an aceptable flavour or serious health consequences of these alternatives generates and active search for safe and sweet healthy products.
Natural monosaccharides (Glucose, Fructose) offer the best sweet flavours, but complicates the course of insulin resistance and/or diabetes tipe 2. By balancing the composition of fructose and glucosa, and the presence of D-Pinitol, we avoid all these unwanted side effects, generating a natural sweetener with healthy properties: prevention of insulin resistance development and avoiding the deposition of fat in the liver.
D-pinitol reduces the plasma peak of glucosa and the unwanted effects of fructose on liver metabolis, including oxidative stress and lipid synthesis, favouring fat oxidation. It prevents hiperinsulinemia, reducing the risk of insulin resistance, making it suitable for diabetes type 2
Liquid viscose
Oral.
High
69.0 – 71.0
min. 45.0% fructose, 40% glucosa and less than 5.0% inositols
1.35 – 1.36 g/ml
Sweet and pleasant fruit aroma
Stable under normal processing and storage conditions.
Disclaimer
Information presented in this leaflet is intended to provide general information on our premium products, their properties and potential applications. It is based on our present state of knowledge and must not be construed as guaranteeing specific properties or approvals of the products described herein or their suitability for any application described. The user is solely responsible for compliance with the existing approvals in the county of use. It is also in the sole responsibility of the user to investigate whether existing patents are infringed by the use of the materials described herein. Adequate quality of our products is guaranteed under our General Conditions of Sales.
All statements in this leaflet have not been evaluated by the US Food and Drug Administration or EFSA. This product is not intended to diagnose, treat, cure, or prevent any disease.
[1] López-Gambero et al. (2020) discuss the potential biomedical uses of inositols in addressing metabolic dysfunction in aging and neurodegenerative diseases
[2] Navarro et al. (2022) Endocrine and Metabolic Impact of Oral Ingestion of a Carob-Pod-Derived Natural-Syrup-Containing D-Pinitol: Potential Use as a Novel Sweetener in Diabetes.
We are purpose-driven biotechnology company committed to responsible research, development, and innovation. We create pharmaceutical ingredients for the prevention and improvement of people´s health.
One Broadway, 14th Floor
Cambridge, MA 02142
United States
+1 (617) 861-6332
advenion@advenion.com
PROGRAMA KIT DIGITAL COFINANCIADO POR LOS FONDOS NEXT GENERATION (EU) DEL MECANISMO DE RECUPERACIÓN Y RESILENCIA